Risk of bleeding and use of platelet transfusions in patients with hematological malignancies: recurrent event analysis

A recent randomized trial (TOPPS) compared prophylactic platelet transfusions (for counts <10x109/L) with a strategy of no-prophylaxis in adults with hematologic malignancies. 70% of enrolled patients received autologous hematopoietic stem cell transplant (HSCT). In this analysis, statistical...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanworth, S, Hudson, C, Estcourt, L, Johnson, R, Wood, E
Formato: Journal article
Publicado: Ferrata Storti Foundation 2015